The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients

Clinica Chimica Acta

Volumn 371, Issue 1-2, 2006, Pages 112-116

  Ławicki, Sławomir ^a   Szmitkowski, Maciej ^a   Wojtukiewicz, Marek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Breast cancer; CA 15 3; HGFs; M CSF; Tumor markers

Indexed keywords

CA 15-3 ANTIGEN; COLONY STIMULATING FACTOR 1;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BREAST NEOPLASMS; CA-15-3 ANTIGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MIDDLE AGED; NEOPLASM STAGING; REAGENT KITS, DIAGNOSTIC; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33746703675     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.02.033     Document Type: Article

References (21)

1. Sasco A. Epidemiology of breast cancer: an environmental disease?. APMIS 109 (2001) 321-332
2. Dunlop R.J., and Campbell C.W. Cytokines and advanced cancer. J Pain Sym Manag 20 (2000) 214-232
3. Chao K., Chang C., Yen M., Wang P., and Ng H. Granulocyte colony-stimulating factor on the growth of human ovarian carcinoma cells in vitro. Gynecol Obstet Invest 48 (1999) 280-284
4. Asschert J.G.W., Vellenga E., Hollema H., van der Zee A.G.J., and de Vries E.G.E. Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-11 (IL-11) and tumour necrosis factor-α (TNF-α) in p53-characterised human ovarian carcinomas. Eur J Cancer 33 (1997) 2246-2251
5. Hines S.J., Litz J.S., and Krystal G.W. Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the family of growth factors. Breast Cancer Res Treat 58 (1999) 1-7
6. Kaciński B.M. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol Reprod Dev 46 (1997) 71-74
7. Yee D.L., and Liu L. The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res 20 (2000) 4379-4384
8. Mancino A.T., Klimberg V.S., Yamamoto M., Manolagas S.C., and Abe E. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells. J Surg Res 100 (2001) 18-24
9. Lin E.Y., Gouon-Evans V., Nguyen V., and Pollard J.W. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7 (2002) 147-162
10. McDermott R.S., Deneux L., Mosseri V., et al. Circulating macrophage colony stimulating factor as a marker of tumour progression. Eur Cytokine Netw 13 (2002) 121-127
11. Scholl S.M., Lidereau R., de la Rochefordiere A., et al. Circulating levels of the macrophage-colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. Breast Cancer Res Treat 39 (1996) 275-283
12. Praloran V. Structure, biosynthesis and biological roles of monocyte-macrophage colony stimulating factor (CSF-1 or M-CSF). Nouv Rev Fr Hematol 33 (1991) 323-333
13. Shadle P.J., Allen J.I., and Geier M.D. Detection of endogenous macrophage colony-stimulating factor (M-CSF) in human blood. Exp Hematol 17 (1989) 154-159
14. Savarese D.M.F., Valiński H., Quesenberry P., and Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 34 (1998) 80-91
15. Parrot J.A., Kim G., and Skinner M.K. Expression and function of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer. Biol Reprod 62 (2000) 1600-1609
16. Mroczko B., Szmitkowski M., Wereszczynska-Siemiatkowska U., and Jurkowska G. Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer. Clin Chem Lab Med 42 (2004) 256-260
17. Kaciński B.M., Chambers S.K., and Stanley E.R. The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumour marker of neoplastic disease activity in endometrial carcinoma patients. Int J Radiat Oncol Biol Phys 19 (1990) 619-626
18. Kaciński B.M. CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 27 (1995) 79-85
19. Scholl S.M., Bascou C.H., and Mosseri V. Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer. Br J Cancer 69 (1994) 342-346
20. Rutkowski P., Kaminska J., Kowalska M., Ruka W., and Steffen J. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int J Cancer 100 (2002) 463-471
21. Kokko R., Holli K., and Hakama M. CA 15-3 in the follow-up of localised breast cancer: a prospective study. Eur J Cancer 38 (2002) 1189-1193